Organization Profile

You just read:

Isracann Biosciences Inc. announces letter of intent for up to $15 million in funding to develop cannabis facilities servicing major undersupplied markets

News provided by

Isracann Biosciences Inc.

Jan 08, 2019, 09:00 ET